Recently, KornnacCaps successfully completed the shipment of Size 0 gelatin capsules to a client in Mexico. These high-quality pharmaceutical capsules will cross the ocean to provide premium excipient support to Mexico's pharmaceutical and healthcare industry. This collaboration not only marks a significant step in KornnacCaps' international strategy but also demonstrates the global competitiveness of Chinese enterprises in the field of pharmaceutical excipients.
As a renowned manufacturer in the industry, KornnacCaps has always adhered to the philosophy of Quality First, Customer Foremost, focusing on the R&D and production of gelatin capsules. The Size 0 gelatin capsules exported this time are one of the company's best-selling products, carefully developed based on years of technical accumulation and market research to meet international client needs. This specific size offers moderate capacity and excellent flowability. Not only does it comply with international pharmacopoeia standards, but it also excels in critical indicators such as shell elasticity, fracture toughness, and disintegration time. These features allow it to accommodate the filling requirements of various drug ingredients, providing a solid guarantee for the stability and efficacy of the pharmaceuticals.
To ensure the exceptional quality of this export batch, KornnacCaps implemented rigorous quality control at every stage, from raw material procurement to production processing. The company selects premium food-grade gelatin as raw material and relies on fully automated production lines and a clean manufacturing environment, supported by advanced testing equipment for full-process monitoring. From weight variation and appearance uniformity to microbial limits, every indicator underwent layers of inspection to ensure the product fully meets export standards and the local regulatory requirements of Mexico. Additionally, to address the characteristics of international logistics, the company optimized its packaging solution, using professional moisture-proof and shock-resistant packaging materials to ensure the capsules maintain their optimal condition during long-distance transport.
As an important pharmaceutical market in Latin America, Mexico has seen growing demand for pharmaceutical excipients and increasingly strict quality requirements. This collaboration with a Mexican client is a key move for KornnacCaps to expand into the American market. A company representative stated, We highly value our collaboration with the Mexican client. This is not only a recognition of KornnacCaps' quality but also a source of confidence as we enter the global market. In the future, we will continue to deepen technological innovation, enhance product competitiveness, and provide high-quality capsule products and services to more international clients.
The successful shipment of these Size 0 gelatin capsules marks the further deepening of KornnacCaps' layout in the international market. With the deep integration of the global pharmaceutical supply chain, KornnacCaps will continue to actively integrate into the global market with superior products and professional services, striving to become a leading enterprise in the global pharmaceutical excipient field and contributing Chinese strength to the global pharmaceutical health cause. Moving forward, the company will continue to expand its overseas market footprint, promoting Made in China pharmaceutical excipients to shine on the international stage.
